MetLife Inc 5.625% Series E Preferred Stock
MET.PRE
1 hedge funds and large institutions have $6.61M invested in MetLife Inc 5.625% Series E Preferred Stock in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.04% less ownership
Funds ownership: 0.89% → 0.85% (-0.04%)
10% less capital invested
Capital invested by funds: $7.33M → $6.61M (-$716K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Middleton & Co
Boston,
Massachusetts
|
-$255K |
| 2 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
-$109K |
MET.PRE Hedge Fund Activity: Q3 2022 in Review
1 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q3 2022, worth a combined $6.61M — down 9.8% from $7.33M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MET.PRE and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Middleton & Co, exiting entirely with an estimated $255K sold.
- 1 institutional investor held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q3 2022, down from 2 in Q2 2022.
- Funds reported $6.61M of MetLife Inc 5.625% Series E Preferred Stock stock for Q3 2022, down 9.8% quarter-over-quarter.
- 0 funds opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest MetLife Inc 5.625% Series E Preferred Stock seller in Q3 2022 was Middleton & Co, an estimated $255K sold.
Based on aggregated 13F filings for Q3 2022.